방사선 진단 서비스 시장 : 점유율 분석, 업계 동향과 통계, 성장 예측(2026-2031년)

According to Mordor Intelligence, the radiology services market size was valued at USD 3.14 billion in 2025 and is estimated to grow from USD 3.64 billion in 2026 to reach USD 8.18 billion by 2031, at a CAGR of 17.59% during the forecast period (2026-2031).

This report is Segmented by Modality (X-Ray, CT, MRI, Ultrasound, and More), Service Type (Diagnostic Imaging, and More), Service Setting (Hospital-Based Imaging, and More), Delivery Model (Owned and Operated Networks, and More), Application (Oncology, and More), End User (Hospitals, Imaging Centers, Others), and Geography (North America, and More). The Market Forecasts are Provided in Terms of Value (USD).

Global Radiology Services Market Trends and Insights

Rising Chronic Disease Burden and Repeat Imaging Demand

The radiology services market is benefiting from a larger pool of patients who need repeated imaging over long periods of care. Cancer, cardiovascular disease, and neurodegenerative disorders often require several scans across diagnosis, treatment planning, response monitoring, and follow-up. That pattern increases the number of billable imaging episodes generated by each patient and raises the value of networks that can provide multiple modalities in one referral pathway. The radiology services market also gains when providers have subspecialty reading depth in oncology and neurology because those cases often require higher-acuity interpretation. This demand pattern favors multi-site operators that can keep patients inside the same network across CT, MRI, PET, and nuclear imaging over time.

Outpatient Shift of Imaging Volumes

The radiology services market is also being lifted by the continued movement of imaging volume away from hospital departments and into lower-cost outpatient settings. Providers and payers both benefit when appropriate studies move into freestanding centers because the service can be delivered with lower overhead and better scheduling flexibility. Hospital systems are not simply losing that volume, because many are building or buying their own outpatient networks to keep referral relationships intact. This is changing local competition in the radiology services market by placing hospital-backed centers in more direct competition with independent operators. The pace of this shift still varies by market because payer mix, local regulation, and certificate-of-need rules affect how quickly new capacity can be added.

Radiologist and Technologist Shortages

The radiology services market continues to face a structural staffing gap that limits how much demand can be converted into finished reads and billed procedures. A 2025 study in the American Journal of Neuroradiology documented a cumulative 10-year deficit of 21,645 anticipated diagnostic radiology graduates relative to job listings between 2014 and 2023. A separate 2026 study reported that radiologist turnover in the United States rose from 5.3% to 8.5% between 2013 and 2022, which shows how workload pressure is affecting retention. The radiology services market is therefore growing faster than the available specialist pool in several mature regions. Providers that expand AI support, shared reading pools, and distributed staffing models are better positioned than operators that still rely only on local in-house teams.

Other drivers and restraints analyzed in the detailed report include:

1. AI-Assisted Workflow Compression in Reading and Triage
2. Expansion of Teleradiology Coverage Across Underserved Facilities
3. Reimbursement Compression in Advanced Imaging

For complete list of drivers and restraints, kindly check the Table Of Contents.

Segment Analysis

Computed tomography is the fastest-growing modality in the radiology services market at 19.24% CAGR from 2026 to 2031, while X-ray remained the leading modality by revenue with market share of 28.53% in 2025. CT is gaining ground because new photon-counting and spectral systems are widening its usefulness across oncology, stroke, cardiac assessment, and complex neurological workups. GE HealthCare received FDA clearance for Photonova Spectra in March 2026, while Philips received FDA clearance for Verida in early 2026, which reinforces commercial momentum behind next-generation CT platforms. These systems support higher clinical value per scan and strengthen the role of CT in fast-moving radiology services market referral pathways.

Ultrasound remains important in the radiology services industry because it supports real-time guidance in interventional settings and fits well with point-of-care workflows. MRI is also evolving as operators respond to helium supply concerns and long-term resilience needs in fleet planning. Siemens Healthineers received FDA clearance in 2025 for Magnetom Flow, and GE HealthCare received clearance in February 2026 for SIGNA Sprint with Freelium, both of which reduce dependence on traditional helium-intensive designs. Mammography and PET or CT are also gaining a larger role in cancer and neurology pathways, which supports a broader modality mix within the radiology services market as referral intensity rises in higher-acuity specialties.

Diagnostic imaging services accounted for 37.38% of the radiology services market size in 2025, while interventional radiology is projected to grow at 22.82% CAGR through 2031. The share leadership of diagnostic imaging reflects its role across almost every routine and advanced clinical workflow, from emergency evaluation to chronic disease monitoring. Growth is stronger in interventional radiology because more procedures are moving from surgical settings into image-guided suites, where providers can offer less invasive care with shorter recovery times. This changes the revenue mix in the radiology services market by increasing the contribution of higher-value, procedure-based work rather than routine scan volumes alone.

CMS reinforced that shift by assigning interventional radiology a positive 2% impact in the 2026 Medicare Physician Fee Schedule while diagnostic imaging categories faced cuts. That payment signal encourages providers to add interventional capacity where referral depth and physician availability can support it. Radiation oncology support services remain smaller in scale, but they are benefiting from closer integration between imaging, targeted therapy planning, and precision treatment workflows. In the radiology services industry, operators with accredited suites, subspecialty physicians, and multi-modality coordination are more likely to capture that shift than general imaging providers with limited procedural capability.

Complete Report Scope:

• By Modality
  • X-Ray
  • Computed Tomography
  • Magnetic Resonance Imaging
  • Ultrasound
  • Nuclear Imaging
  • Mammography
  • Positron Emission Tomography
  • Other Modalities
• By Service Type
  • Diagnostic Imaging
  • Interventional Radiology
  • Radiation Oncology Support Services
• By Service Setting
  • Hospital-Based Imaging
  • Freestanding Imaging Centers
  • Community Diagnostic Centers
  • Mobile Imaging Units
• By Delivery Model
  • Owned and Operated Networks
  • Teleradiology-Enabled Networks
  • Hospital Joint Ventures
  • Managed Services and Outsourcing
• By Application
  • Oncology
  • Neurology and Spine
  • Cardiology
  • Orthopedics and Musculoskeletal
  • Chest and Pulmonary Imaging
  • Women's Health and Obstetrics
  • General Imaging
• By End User
  • Hospitals
  • Diagnostic Imaging Centers
  • Ambulatory Centers
  • Clinics
  • Research and Academic Institutions
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • Germany
    • United Kingdom
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • Middle East & Africa
    • GCC
    • South Africa
    • Rest of Middle East & Africa
  • South America
    • Brazil
    • Argentina
    • Rest of South America

Geography Analysis

North America accounted for 38.63% of the radiology services market share in 2025, which kept it as the largest regional contributor. The region benefits from high imaging procedure density, deep reimbursement infrastructure, and a large installed base of advanced equipment. The radiology services market in the United States is also seeing more consolidation as national operators expand through acquisitions, joint ventures, and digital health investments. RadNet's 2026 guidance pointed to 17% to 19% imaging center revenue growth and 46% to 56% digital health revenue growth, which shows how large operators are broadening their business models beyond core scanning services. CMS rules that require faster prior authorization response times for Medicare Advantage from 2026 may also reduce imaging delays and improve throughput in parts of the North American radiology services market.

Europe remains strategically important in the radiology services market because imaging demand is high, but reimbursement systems vary widely across countries. France reported 7.0% growth in imaging expenditure in 2024, even as imaging prices declined 1.0%, which highlights the importance of scale and utilization in maintaining revenue. Germany still anchors market depth in Europe, while pan-European groups continue to balance mature-market optimization with selective expansion into underpenetrated markets. The radiology services market in Europe also faces heavier data and interoperability obligations, which raise compliance costs but can strengthen long-term platform quality for operators that adapt early.

Asia-Pacific is the fastest-growing region in the radiology services market at 20.38% CAGR from 2026 to 2031. Growth is being supported by healthcare infrastructure spending, rising chronic disease incidence, and a continuing shortage of radiologists in several countries. Those conditions make teleradiology and digital workflow tools especially relevant across both developed and emerging Asia-Pacific systems. China is drawing investment into digital radiology infrastructure that improves cloud-based image sharing between hospitals and off-site radiologists. The Middle East and Africa remain smaller in scale, but Gulf markets are supporting premium equipment demand while MRI-heavy providers remain exposed to helium supply volatility. South America offers selective growth potential, with Brazil continuing to account for the largest part of regional demand through private diagnostic center networks and growing middle-income utilization.

1. Affidea Group
2. Akumin Inc.
3. Alliance Medical Group
4. Everlight Radiology
5. FUJIFILM
6. GE HealthCare Technologies Inc.
7. HCA Healthcare, Inc.
8. I-MED Radiology Network
9. Koninklijke Philips
10. Mednax, Inc.
11. ONRAD
12. RadNet, Inc.
13. Radiology Partners, Inc.
14. Ramsay Health Care Limited
15. RAYUS Radiology
16. Siemens Healthineers
17. SimonMed Imaging
18. Sonic Healthcare
19. Unilabs

Additional Benefits:

• The market estimate (ME) sheet in Excel format
• 3 months of analyst support

TABLE OF CONTENTS

1 Introduction

• 1.1 Study Assumptions & Market Definition
• 1.2 Scope of the Study

2 Research Methodology

3 Executive Summary

4 Market Landscape

• 4.1 Market Overview
• 4.2 Market Drivers
  • 4.2.1 Rising Chronic Disease Burden and Repeat Imaging Demand
  • 4.2.2 Outpatient Shift of Imaging Volumes
  • 4.2.3 AI-Assisted Workflow Compression in Reading and Triage
  • 4.2.4 Expansion of Teleradiology Coverage Across Underserved Facilities
  • 4.2.5 Prior Authorization Friction Redirecting Volume to Networked Providers
  • 4.2.6 Helium and Contrast Supply Resilience Becoming a Service Differentiator
• 4.3 Market Restraints
  • 4.3.1 Radiologist and Technologist Shortages
  • 4.3.2 Reimbursement Compression in Advanced Imaging
  • 4.3.3 High CAPEX and Replacement Cycle Dependency
  • 4.3.4 Data Privacy and Interoperability Burden Across Distributed Networks
• 4.4 Value / Supply-Chain Analysis
• 4.5 Regulatory Landscape
• 4.6 Technological Outlook
• 4.7 Porter's Five Forces Analysis
  • 4.7.1 Threat of New Entrants
  • 4.7.2 Bargaining Power of Suppliers
  • 4.7.3 Bargaining Power of Buyers
  • 4.7.4 Threat of Substitutes
  • 4.7.5 Industry Rivalry

5 Market Size & Growth Forecasts

• 5.1 By Modality
  • 5.1.1 X-Ray
  • 5.1.2 Computed Tomography
  • 5.1.3 Magnetic Resonance Imaging
  • 5.1.4 Ultrasound
  • 5.1.5 Nuclear Imaging
  • 5.1.6 Mammography
  • 5.1.7 Positron Emission Tomography
  • 5.1.8 Other Modalities
• 5.2 By Service Type
  • 5.2.1 Diagnostic Imaging
  • 5.2.2 Interventional Radiology
  • 5.2.3 Radiation Oncology Support Services
• 5.3 By Service Setting
  • 5.3.1 Hospital-Based Imaging
  • 5.3.2 Freestanding Imaging Centers
  • 5.3.3 Community Diagnostic Centers
  • 5.3.4 Mobile Imaging Units
• 5.4 By Delivery Model
  • 5.4.1 Owned and Operated Networks
  • 5.4.2 Teleradiology-Enabled Networks
  • 5.4.3 Hospital Joint Ventures
  • 5.4.4 Managed Services and Outsourcing
• 5.5 By Application
  • 5.5.1 Oncology
  • 5.5.2 Neurology and Spine
  • 5.5.3 Cardiology
  • 5.5.4 Orthopedics and Musculoskeletal
  • 5.5.5 Chest and Pulmonary Imaging
  • 5.5.6 Women's Health and Obstetrics
  • 5.5.7 General Imaging
• 5.6 By End User
  • 5.6.1 Hospitals
  • 5.6.2 Diagnostic Imaging Centers
  • 5.6.3 Ambulatory Centers
  • 5.6.4 Clinics
  • 5.6.5 Research and Academic Institutions
• 5.7 By Geography
  • 5.7.1 North America
    • 5.7.1.1 United States
    • 5.7.1.2 Canada
    • 5.7.1.3 Mexico
  • 5.7.2 Europe
    • 5.7.2.1 Germany
    • 5.7.2.2 United Kingdom
    • 5.7.2.3 France
    • 5.7.2.4 Italy
    • 5.7.2.5 Spain
    • 5.7.2.6 Rest of Europe
  • 5.7.3 Asia-Pacific
    • 5.7.3.1 China
    • 5.7.3.2 Japan
    • 5.7.3.3 India
    • 5.7.3.4 Australia
    • 5.7.3.5 South Korea
    • 5.7.3.6 Rest of Asia-Pacific
  • 5.7.4 Middle East & Africa
    • 5.7.4.1 GCC
    • 5.7.4.2 South Africa
    • 5.7.4.3 Rest of Middle East & Africa
  • 5.7.5 South America
    • 5.7.5.1 Brazil
    • 5.7.5.2 Argentina
    • 5.7.5.3 Rest of South America

6 Competitive Landscape

• 6.1 Market Concentration
• 6.2 Market Share Analysis
• 6.3 Company Profiles (includes Global Level Overview, Market-level Overview, Core Segments, Financials, Strategic Information, Market Rank/Share, Products & Services, Recent Developments)
  • 6.3.1 Affidea Group
  • 6.3.2 Akumin Inc.
  • 6.3.3 Alliance Medical Group
  • 6.3.4 Everlight Radiology
  • 6.3.5 Fujifilm Holdings Corporation
  • 6.3.6 GE HealthCare Technologies Inc.
  • 6.3.7 HCA Healthcare, Inc.
  • 6.3.8 I-MED Radiology Network
  • 6.3.9 Koninklijke Philips N.V.
  • 6.3.10 Mednax, Inc.
  • 6.3.11 ONRAD, Inc.
  • 6.3.12 RadNet, Inc.
  • 6.3.13 Radiology Partners, Inc.
  • 6.3.14 Ramsay Health Care Limited
  • 6.3.15 RAYUS Radiology
  • 6.3.16 Siemens Healthineers AG
  • 6.3.17 SimonMed Imaging
  • 6.3.18 Sonic Healthcare Limited
  • 6.3.19 Unilabs

7 Market Opportunities & Future Outlook

• 7.1 White-space & Unmet-need Assessment